How we will use your data to ensure effective
engagement with you
The
DPS UnifyTM mobile
application have been developed and is managed by AstraZeneca UK Ltd, a private
limited company registered in England and Wales under company number 03674842
with registered offices at 1 Francis Crick Avenue, Cambridge Biomedical Campus,
Cambridge, CB2 0AA (“AstraZeneca”),
AstraZeneca will collect and use some of your personal data that we obtain from you and your healthcare professional via the DPS UnifyTM mobile application for the purposes of onboard patients to clinical trials and allow for ways to contact between HCP and Patients when necessary.
The DPS UnifyTM mobile application also deliver an optimal clinical trial experience for each individual patient, healthcare professionals and AstraZeneca staff. It will also create a single interface and experience for investigators by aggregating all features and functionality related to site, trial and patient administration/management into one unified platform.
We will use your personal data based on AstraZeneca’s legal requirements that cover the conduct of clinical studies and public interest
What personal information will be collected:
We may process the following categories of data which will be provided by you or your healthcare professional: Personal characteristics (such as date of birth), Personal Contact Details (such as email address, phone number, preferred language and country), System User details (such as patient eCode , UserID and password), information about your participation in clinical trials and non-interventional studies. Except for your personal contact details, all other personal data will be coded. We do this replacing your name/contact details with a code. This is done by the study doctor who keeps the link between your name/ contact details and the code to ensure your safety and confidentiality.
The DPS Unify app can be used to collect data from Bluetooth-connected devices when the app is in the background and when it is being used. For technical reasons, some versions of the Android operating system implementing Bluetooth communication may temporarily access location data. The app does not store your location data or use your location for any tracking purposes.
Coded information cannot directly identify you unless your study doctor provides your name or contact details, where allowed by applicable law.
Sharing
your information:
Only your healthcare professional and staff
working at the hospital and minimum IT support personnel from both AstraZeneca
and its trusted third parties will have access to data that personally
identifies you. Any other parties will only have access to coded data so that
you cannot be personally identified.
Your personal information may be shared with other AstraZeneca group companies (https://www.astrazeneca.com/global/en/AstraZeneca-Websites.html). We may also share your personal data with certain third parties, such as: IT providers for the purposes of operating, administrating, supporting and managing the DPS UnifyTM mobile application, companies that provide services to AstraZeneca to conduct the clinical studies, organisations which collaborates with AstraZeneca on the clinical trials, health authorities and ethics committees who supervise the study, who approve the commercialisation of the drug or who receive the adverse events reporting, auditors and consultants to verify our compliance with external and internal requirements; statutory bodies, law enforcement agencies and litigants, as per a legal reporting requirement or claim; and a successor or business partner to AstraZeneca or to an AstraZeneca group company in the event that it sells, divests or sets up a collaboration/joint venture for all or part of its business.
International
Transfers:
AstraZeneca entities and third parties may be based anywhere in the world,
which could include countries that may not offer the same legal protections for
personal data as your country of residence. AstraZeneca will follow local data
protection requirements and its internal global privacy
standard and will apply the
necessary safeguards under the applicable law of the country transferring the
data for such transfers. Irrespective of which country your Personal Data is
transferred, We would only share your personal data under a strict ‘need to
know’ basis and under appropriate contractual restrictions (such as
AstraZeneca’s
Binding Corporate Rules and EU Standard Contract
Clauses or equivalent
instruments approved by the European Commission or by the Supervisory
Authority). You are entitled to receive a copy of AstraZeneca’s Binding
Corporate Rules and/or the AstraZeneca’s EU Standard Contract Clauses upon
request by contacting AstraZeneca on Privacy@astrazeneca.com.
Retaining your information
Your contact details and other personal data that directly identify you will be retained in the DPS UnifyTM mobile application only as necessary to deliver this service to you and to comply with applicable laws. If you are in an ongoing trail this information and you connection to your eCode will be removed maximum 4 weeks after the end of the trial. However, the study site and AstraZeneca are obliged by law to keep your coded data such as your medication intake, how you take your medication, response to questionnaires, for a period of up to 15 years after the end of the study or for as long as it is necessary in order to satisfy our legitimate business interests, legal obligations, or in order to establish, exercise or defend legal claims. After that your coded data will be deleted or anonymized. For more information on AstraZeneca internal Document Retention policy you may go to www.astrazenecapersonaldataretention.com
Your
rights:
You can stop using the app at any time by telling your
healthcare professional and uninstalling the app from your phone. Your profile
and contact details will then be removed but any coded data will be retained as
described under the headline “Retaining your information”.You may
contact your study doctor to request access to the data we hold about you, to
correct any mistakes or to request deletion of the same. If such a
request places AstraZeneca or its affiliates in breach of its obligations under
applicable laws, regulations or codes of practice, then AstraZeneca may not be
able to comply with your request but you may still be able to request that we
block the use of your personal information for further processing. in breach of its obligations under applicable laws,
regulations or codes of practice, then AstraZeneca may not be able to comply
with your request but you may still be able to request that we block the use of
your personal information for further processing. You may also have a right to
data portability to another Data Controller under certain circumstances.
How your information
will be protected:
AstraZeneca
has assigned a Data Protection Officer responsible for overseeing AstraZeneca’s
compliance with EU data protection law, which you may contact at Privacy@astrazeneca.com in case of any questions or concerns regarding the processing of your
personal data. If AstraZeneca’s processing of your personal data is covered by
EU law you may also lodge a complaint with the corresponding Data Protection
Supervisory Authority in your country of residence. You can find the relevant
Supervisory Authority name and contact details under http://ec.europa.eu/justice/data-protection/bodies/authorities/index_en.htm.
Last reviewed: February
2022
Version 1.2